Literature DB >> 22848302

Estradiol induces JNK-dependent apoptosis in glioblastoma cells.

Nedret Altiok1, Melike Ersoz, Meral Koyuturk.   

Abstract

Estrogens exert multiple regulatory actions on cellular events in a variety of tissues including the brain. In the present study, the signaling mechanisms of the concentration-dependent effects of 17-β-estradiol (estradiol) on glioblastoma cells were investigated. Cell viability was evaluated by the trypan blue exclusion assay. Cell growth and kinase activities were evaluated by immunocytochemistry and Western blotting. The results showed that high concentrations of estradiol inhibit growth and induce apoptosis in C6 rat glioma and T98G human glioblastoma cells. The blockade of the c-jun NH(2)-terminal kinase (JNK) signaling pathway prevented these effects of estradiol, indicating the critical role of the JNK/c-jun signaling cascade in glioblastoma cell growth inhibition and cell death in response to high concentrations of estradiol. Collectively, these findings highlight the potential of new discoveries in sensitizing estrogen-sensitive tumors to chemotherapeutic drugs, and may lead to the development of new JNK-based effective therapies.

Entities:  

Year:  2011        PMID: 22848302      PMCID: PMC3406496          DOI: 10.3892/ol.2011.385

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

Review 1.  Contribution of estrogen receptors alpha and beta to the effects of estradiol in the brain.

Authors:  M Morissette; M Le Saux; M D'Astous; S Jourdain; S Al Sweidi; N Morin; E Estrada-Camarena; Pablo Mendez; Luis Miguel Garcia-Segura; T Di Paolo
Journal:  J Steroid Biochem Mol Biol       Date:  2007-09-07       Impact factor: 4.292

2.  All JNKs can kill, but nuclear localization is critical for neuronal death.

Authors:  Benny Björkblom; Jenni C Vainio; Vesa Hongisto; Thomas Herdegen; Michael J Courtney; Eleanor T Coffey
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

3.  SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.

Authors:  B L Bennett; D T Sasaki; B W Murray; E C O'Leary; S T Sakata; W Xu; J C Leisten; A Motiwala; S Pierce; Y Satoh; S S Bhagwat; A M Manning; D W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.

Authors:  Nedret Altiok; Meral Koyuturk; Soner Altiok
Journal:  Breast Cancer Res Treat       Date:  2006-12-23       Impact factor: 4.872

5.  Diverse somatic mutation patterns and pathway alterations in human cancers.

Authors:  Zhengyan Kan; Bijay S Jaiswal; Jeremy Stinson; Vasantharajan Janakiraman; Deepali Bhatt; Howard M Stern; Peng Yue; Peter M Haverty; Richard Bourgon; Jianbiao Zheng; Martin Moorhead; Subhra Chaudhuri; Lynn P Tomsho; Brock A Peters; Kanan Pujara; Shaun Cordes; David P Davis; Victoria E H Carlton; Wenlin Yuan; Li Li; Weiru Wang; Charles Eigenbrot; Joshua S Kaminker; David A Eberhard; Paul Waring; Stephan C Schuster; Zora Modrusan; Zemin Zhang; David Stokoe; Frederic J de Sauvage; Malek Faham; Somasekar Seshagiri
Journal:  Nature       Date:  2010-07-28       Impact factor: 49.962

6.  Distinct signaling pathways of microtubule inhibitors--vinblastine and Taxol induce JNK-dependent cell death but through AP-1-dependent and AP-1-independent mechanisms, respectively.

Authors:  Sergey N Kolomeichuk; David T Terrano; Christopher S Lyle; Kanaga Sabapathy; Timothy C Chambers
Journal:  FEBS J       Date:  2008-03-13       Impact factor: 5.542

Review 7.  The two faces of estradiol: effects on the developing brain.

Authors:  Margaret M McCarthy
Journal:  Neuroscientist       Date:  2009-12       Impact factor: 7.519

8.  c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.

Authors:  E D Lagadinou; P G Ziros; O A Tsopra; K Dimas; D Kokkinou; E Thanopoulou; M Karakantza; P Pantazis; A Spyridonidis; N C Zoumbos
Journal:  Leukemia       Date:  2008-07-24       Impact factor: 11.528

9.  Apoptosis induced by cytoskeletal disruption requires distinct domains of MEKK1.

Authors:  Erin Tricker; Afsane Arvand; Raymond Kwan; Gordon Y Chen; Ewen Gallagher; Genhong Cheng
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

10.  AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.

Authors:  Shuraila F Zerp; Rianne Stoter; Gitta Kuipers; Dajun Yang; Marc E Lippman; Wim J van Blitterswijk; Harry Bartelink; Rogier Rooswinkel; Vincent Lafleur; Marcel Verheij
Journal:  Radiat Oncol       Date:  2009-10-23       Impact factor: 3.481

View more
  11 in total

1.  XAF1 destabilizes estrogen receptor α through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis.

Authors:  Ji-Sun Lim; Kyung-Woo Lee; Kyung-Phil Ko; Seong-In Jeong; Byung-Kyu Ryu; Min-Goo Lee; Sung-Gil Chi
Journal:  Oncogene       Date:  2022-04-16       Impact factor: 9.867

2.  Drug repurposing for glioblastoma based on molecular subtypes.

Authors:  Yang Chen; Rong Xu
Journal:  J Biomed Inform       Date:  2016-09-30       Impact factor: 6.317

3.  Potent inhibitory effect of δ-tocopherol on prostate cancer cells cultured in vitro and grown as xenograft tumors in vivo.

Authors:  Huarong Huang; Yan He; Xiao-Xing Cui; Susan Goodin; Hong Wang; Zhi Yun Du; Dongli Li; Kun Zhang; Ah-Ng Tony Kong; Robert S DiPaola; Chung S Yang; Allan H Conney; Xi Zheng
Journal:  J Agric Food Chem       Date:  2014-10-27       Impact factor: 5.279

4.  Trypan blue exclusion assay by flow cytometry.

Authors:  B A Avelar-Freitas; V G Almeida; M C X Pinto; F A G Mourão; A R Massensini; O A Martins-Filho; E Rocha-Vieira; G E A Brito-Melo
Journal:  Braz J Med Biol Res       Date:  2014-03-18       Impact factor: 2.590

Review 5.  Glioblastoma multiforme - an overview.

Authors:  Kaja Urbańska; Justyna Sokołowska; Maciej Szmidt; Paweł Sysa
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-04

6.  Towards precision medicine-based therapies for glioblastoma: interrogating human disease genomics and mouse phenotypes.

Authors:  Yang Chen; Zhen Gao; Bingcheng Wang; Rong Xu
Journal:  BMC Genomics       Date:  2016-08-22       Impact factor: 3.969

7.  Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells.

Authors:  Minqian Shen; Haifei Shi
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 8.  Astrocytoma: A Hormone-Sensitive Tumor?

Authors:  Alex Hirtz; Fabien Rech; Hélène Dubois-Pot-Schneider; Hélène Dumond
Journal:  Int J Mol Sci       Date:  2020-11-30       Impact factor: 5.923

Review 9.  Control of IGFBP-2 Expression by Steroids and Peptide Hormones in Vertebrates.

Authors:  Andreas Hoeflich; Elisa Wirthgen; Robert David; Carl Friedrich Classen; Marion Spitschak; Julia Brenmoehl
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-07       Impact factor: 5.555

10.  Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells.

Authors:  Carlo Castruccio Castracani; Lucia Longhitano; Alfio Distefano; Daniela Anfuso; Stavroula Kalampoka; Enrico La Spina; Marinella Astuto; Roberto Avola; Massimo Caruso; Daria Nicolosi; Cesarina Giallongo; Daniele Tibullo; Giovanni Li Volti
Journal:  J Oncol       Date:  2020-02-14       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.